Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-053880
Filing Date
2026-08-06
Accepted
2026-08-06 08:03:08
Documents
65
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlyb-20260630.htm   iXBRL 10-Q 1303849
2 EX-31.1 rlyb-20260630xex311.htm EX-31.1 10365
3 EX-31.2 rlyb-20260630xex312.htm EX-31.2 10354
4 EX-32.1 rlyb-20260630xex321.htm EX-32.1 4923
5 EX-32.2 rlyb-20260630xex322.htm EX-32.2 4905
11 rlyb-20260630_g1.jpg GRAPHIC 8945
  Complete submission text file 0001628280-26-053880.txt   6055363

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20260630.xsd EX-101.SCH 40414
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlyb-20260630_cal.xml EX-101.CAL 51688
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlyb-20260630_def.xml EX-101.DEF 194008
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20260630_lab.xml EX-101.LAB 568316
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20260630_pre.xml EX-101.PRE 376328
69 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20260630_htm.xml XML 595456
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

EIN.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40693 | Film No.: 261246123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)